![](\"https:\/\/mms.businesswire.com\/media\/20231114603314\/en\/649252\/4\/AtriCure_logo_1-color_RBG_Web_010218.jpg\"){kind=logo}
<\/a><\/a><\/p>\n\n\u201cAt AtriCure, our focus on making a positive difference for patients is at the heart of our ESG strategy,\u201d said Michael Carrel, President and Chief Executive Officer at AtriCure. \u201cAs we continue to grow, so does our responsibility to operate sustainably and with an unrelenting focus on helping patients, supporting our people, and being exemplary partners. We are committed to further advancing our ESG programs and improving transparency on our focus areas in the years ahead.\u201d<\/p>\n
\nKey accomplishments detailed in AtriCure\u2019s 2023 ESG Report include:<\/p>\n
- \n
- \nReceiving recognition for Diversity, Equity & Inclusion from the National Association of Corporate Directors (NACD). <\/b>AtriCure received the 2022 Diversity, Equity & Inclusion Award from the NACD as the top company in the Small Cap – Public Company category. This award recognizes boards that have improved their governance and created long-term value for stakeholders by implementing forward-thinking diversity, equity, and inclusion (DE&I) practices.<\/li>\n
- \nLaunching key clinical trials and research studies focused on new markets for patients who have limited treatment options. <\/b>These include the landmark Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial (LeAAPS), HEAL-IST to evaluate treatment for Inappropriate Sinus Tachycardia, Investigator-Sponsored Research (ISR) on non-opioid pain relief, and others.<\/li>\n
- \nCultivating an early pipeline of talent and enhancing employee learning and development. <\/b>AtriCure created unique opportunities for educational work and experience during 2022 for participating students and established a learning forum for AtriCure leaders focused on emotional intelligence, DE&I, and essential business skills.<\/li>\n
- \nStrengthening relationships across our supply chain. <\/b>AtriCure has been engaging key business partners through thoughtful dialogue and other efforts, including holding a Supplier Summit we expect to host on an annual basis going forward.<\/li>\n
- \nExpanding education to new audiences, including our groundbreaking Women\u2019s Cardiac Health Awareness Program. <\/b>AtriCure started this initiative to encourage a collaborative approach to addressing gaps in cardiac healthcare for women by bringing together leaders in cardiac surgery, electrophysiology, and thoracic surgery.<\/li>\n<\/ul>\n
\nAtriCure\u2019s 2023 ESG Report aims to address the company\u2019s diverse stakeholders who are interested in ESG-related information, including investors, customers, employees, communities, suppliers, and patients. This report also addresses the Sustainability Accounting Standards Board (SASB) disclosure topics for the Medical Equipment and Supplies industry. Please visit the \u201cCorporate Responsibility\u201d section under \u201cAbout AtriCure\u201d of the company\u2019s website at www.atricure.com\/esg<\/a> to view the report.<\/p>\n
\nAbout AtriCure<\/b><\/p>\n
\nAtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure\u2019s Isolator\u00ae<\/sup> Synergy\u2122 Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure\u2019s AtriClip\u00ae<\/sup> Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure\u2019s Hybrid AF\u2122 Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure\u2019s cryoICE cryoSPHERE\u00ae <\/sup>probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.<\/p>\n
Contacts<\/b> <\/p>\n
\nAngie Wirick
\n
AtriCure, Inc.
\n
Chief Financial Officer
\n
(513) 755-5334
\n
awirick@atricure.com<\/a><\/p>\n\nLynn Lewis or Marissa Bych
\n
Gilmartin Group
\n
Investor Relations
\n
lynn@gilmartinir.com<\/a>
marissa@gilmartinir.com<\/a><\/p>\n\n\n <\/div>\n\n<\/span>","protected":false},"excerpt":{"rendered":"MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company has published its 2023 Environmental, Social and Governance (ESG) Report highlighting the company\u2019s corporate responsibility and sustainability initiatives. \u201cAt AtriCure, our focus on […]<\/p>\n","protected":false},"author":15,"featured_media":14454,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[72],"tags":[],"acf":[],"yoast_head":"\n
AtriCure Releases 2023 ESG Report - ESG Today<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AtriCure Releases 2023 ESG Report - ESG Today\" \/>\n<meta property=\"og:description\" content=\"MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company has published its 2023 Environmental, Social and Governance (ESG) Report highlighting the company\u2019s corporate responsibility and sustainability initiatives. \u201cAt AtriCure, our focus on […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\" \/>\n<meta property=\"og:site_name\" content=\"ESG Today\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ESGToday\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-14T16:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231114603314\/en\/649252\/21\/AtriCure_logo_1-color_RBG_Web_010218.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@EsgToday\" \/>\n<meta name=\"twitter:site\" content=\"@EsgToday\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\/\/www.esgtoday.com\/#\/schema\/person\/44e4c987d2800324e4e9f8a30276cec8\"},\"headline\":\"AtriCure Releases 2023 ESG Report\",\"datePublished\":\"2023-11-14T16:00:00+00:00\",\"dateModified\":\"2023-11-14T16:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\"},\"wordCount\":603,\"publisher\":{\"@id\":\"https:\/\/www.esgtoday.com\/#organization\"},\"articleSection\":[\"Business Wire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\",\"url\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\",\"name\":\"AtriCure Releases 2023 ESG Report - ESG Today\",\"isPartOf\":{\"@id\":\"https:\/\/www.esgtoday.com\/#website\"},\"datePublished\":\"2023-11-14T16:00:00+00:00\",\"dateModified\":\"2023-11-14T16:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.esgtoday.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AtriCure Releases 2023 ESG Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.esgtoday.com\/#website\",\"url\":\"https:\/\/www.esgtoday.com\/\",\"name\":\"ESG Today\",\"description\":\"ESG investing news, analysis, research and information\",\"publisher\":{\"@id\":\"https:\/\/www.esgtoday.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.esgtoday.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.esgtoday.com\/#organization\",\"name\":\"ESG Today\",\"url\":\"https:\/\/www.esgtoday.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.esgtoday.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.esgtoday.com\/wp-content\/uploads\/2023\/05\/ESG-Today-Logo.png\",\"contentUrl\":\"https:\/\/www.esgtoday.com\/wp-content\/uploads\/2023\/05\/ESG-Today-Logo.png\",\"width\":618,\"height\":350,\"caption\":\"ESG Today\"},\"image\":{\"@id\":\"https:\/\/www.esgtoday.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ESGToday\/\",\"https:\/\/twitter.com\/EsgToday\",\"https:\/\/www.linkedin.com\/company\/esg-today\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.esgtoday.com\/#\/schema\/person\/44e4c987d2800324e4e9f8a30276cec8\",\"name\":\"Business Wire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.esgtoday.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a7f879bf2f82f64c6d18d5871e42aa1f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a7f879bf2f82f64c6d18d5871e42aa1f?s=96&d=mm&r=g\",\"caption\":\"Business Wire\"},\"url\":\"https:\/\/www.esgtoday.com\/author\/websupportbusinesswire-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AtriCure Releases 2023 ESG Report - ESG Today","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/","og_locale":"en_US","og_type":"article","og_title":"AtriCure Releases 2023 ESG Report - ESG Today","og_description":"MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company has published its 2023 Environmental, Social and Governance (ESG) Report highlighting the company\u2019s corporate responsibility and sustainability initiatives. \u201cAt AtriCure, our focus on […]","og_url":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/","og_site_name":"ESG Today","article_publisher":"https:\/\/www.facebook.com\/ESGToday\/","article_published_time":"2023-11-14T16:00:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231114603314\/en\/649252\/21\/AtriCure_logo_1-color_RBG_Web_010218.jpg"}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_creator":"@EsgToday","twitter_site":"@EsgToday","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/#article","isPartOf":{"@id":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/"},"author":{"name":"Business Wire","@id":"https:\/\/www.esgtoday.com\/#\/schema\/person\/44e4c987d2800324e4e9f8a30276cec8"},"headline":"AtriCure Releases 2023 ESG Report","datePublished":"2023-11-14T16:00:00+00:00","dateModified":"2023-11-14T16:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/"},"wordCount":603,"publisher":{"@id":"https:\/\/www.esgtoday.com\/#organization"},"articleSection":["Business Wire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/","url":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/","name":"AtriCure Releases 2023 ESG Report - ESG Today","isPartOf":{"@id":"https:\/\/www.esgtoday.com\/#website"},"datePublished":"2023-11-14T16:00:00+00:00","dateModified":"2023-11-14T16:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.esgtoday.com\/atricure-releases-2023-esg-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.esgtoday.com\/"},{"@type":"ListItem","position":2,"name":"AtriCure Releases 2023 ESG Report"}]},{"@type":"WebSite","@id":"https:\/\/www.esgtoday.com\/#website","url":"https:\/\/www.esgtoday.com\/","name":"ESG Today","description":"ESG investing news, analysis, research and information","publisher":{"@id":"https:\/\/www.esgtoday.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.esgtoday.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.esgtoday.com\/#organization","name":"ESG Today","url":"https:\/\/www.esgtoday.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.esgtoday.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.esgtoday.com\/wp-content\/uploads\/2023\/05\/ESG-Today-Logo.png","contentUrl":"https:\/\/www.esgtoday.com\/wp-content\/uploads\/2023\/05\/ESG-Today-Logo.png","width":618,"height":350,"caption":"ESG Today"},"image":{"@id":"https:\/\/www.esgtoday.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ESGToday\/","https:\/\/twitter.com\/EsgToday","https:\/\/www.linkedin.com\/company\/esg-today\/"]},{"@type":"Person","@id":"https:\/\/www.esgtoday.com\/#\/schema\/person\/44e4c987d2800324e4e9f8a30276cec8","name":"Business Wire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.esgtoday.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a7f879bf2f82f64c6d18d5871e42aa1f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a7f879bf2f82f64c6d18d5871e42aa1f?s=96&d=mm&r=g","caption":"Business Wire"},"url":"https:\/\/www.esgtoday.com\/author\/websupportbusinesswire-com\/"}]}},"builder_content":"","_links":{"self":[{"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/posts\/14453"}],"collection":[{"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/comments?post=14453"}],"version-history":[{"count":0,"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/posts\/14453\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/media\/14454"}],"wp:attachment":[{"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/media?parent=14453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/categories?post=14453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.esgtoday.com\/wp-json\/wp\/v2\/tags?post=14453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} - \nLaunching key clinical trials and research studies focused on new markets for patients who have limited treatment options. <\/b>These include the landmark Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial (LeAAPS), HEAL-IST to evaluate treatment for Inappropriate Sinus Tachycardia, Investigator-Sponsored Research (ISR) on non-opioid pain relief, and others.<\/li>\n